The ways in which pharmaceutical companies market their drugs directly to consumers in the U.S. could face quite the evolution in 2025—at least, if legislators and other government powers have ...
Direct-to-consumer advertising (DTCA) of prescription medicines is a marketing practice by which pharmaceutical manufacturers communicate drug information directly to patients rather than through ...
Hosted on MSN
Trump aims to curb direct-to-consumer ads for drugs. Hims & Hers Health could be targeted.
President Donald Trump’s administration on Tuesday rolled out a memorandum aimed at limiting direct-to-consumer advertising for pharmaceuticals, with one senior administration official indicating that ...
Although there have been calls to forbid direct-to-consumer advertising of prescription drugs in the US, legislators have not acted decisively. Is there a way forward? This past fall, ubiquitous ...
On September 16, 2025, the U.S. Food and Drug Administration (FDA) released more than 60 warning letters sent to specific pharmaceutical manufacturers, alleging misbranding of a particular drug ...
Tamar Abrams had a lousy couple of years in 2022 and '23. Both her parents died; a relationship ended; she retired from communications consulting. She moved from Arlington, Virginia, to Warren, Rhode ...
The bill would only prohibit direct-to-consumer advertising of approved prescription pharmaceuticals and biologics, sparing medical devices, dietary supplements, cosmetics, over-the-counter drugs, ...
Hims & Hers Health's ads have been getting attention from the Trump administration. President Donald Trump's administration on Tuesday rolled out a memorandum aimed at limiting direct-to-consumer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results